wasn't initially, the credit raising to be used to fund the trial ? what happens now that $15m has been been used to increase PYC's shareholding in Vision Pharma. Does it mean another c/r for later next year ?
Ann: Conclusion of Genentech Antimicrobial Collaboration, page-7
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $933.2M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 19.3¢ | $521.1K | 2.626M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 124915 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 238526 | 8 |
View Market Depth
| Last trade - 14.07pm 17/10/2024 (20 minute delay) ? |
| PYC (ASX) Chart |